Search Results - "GIN, Alfred S"
-
1
Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent
Published in Drugs (New York, N.Y.) (01-04-2016)“…Eravacycline is an investigational, synthetic fluorocycline antibacterial agent that is structurally similar to tigecycline with two modifications to the…”
Get full text
Journal Article -
2
Solithromycin: A Novel Fluoroketolide for the Treatment of Community-Acquired Bacterial Pneumonia
Published in Drugs (New York, N.Y.) (01-12-2016)“…Solithromycin is a novel fluoroketolide developed in both oral and intravenous formulations to address increasing macrolide resistance in pathogens causing…”
Get full text
Journal Article -
3
Association between fluoroquinolone usage and a dramatic rise in ciprofloxacin-resistant Streptococcus pneumoniae in Canada, 1997–2006
Published in International journal of antimicrobial agents (01-07-2009)“…Abstract This study evaluated the prevalence of fluoroquinolone usage and investigated the association between usage and resistance in respiratory isolates of…”
Get full text
Journal Article -
4
Imipenem–Relebactam and Meropenem–Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations
Published in Drugs (New York, N.Y.) (2018)“…Relebactam (formerly known as MK-7655) is a non-β-lactam, bicyclic diazabicyclooctane, β-lactamase inhibitor that is structurally related to avibactam,…”
Get full text
Journal Article -
5
Ceftazidime-Avibactam: a Novel Cephalosporin/β-lactamase Inhibitor Combination
Published in Drugs (New York, N.Y.) (01-02-2013)“…Avibactam (formerly NXL104, AVE1330A) is a synthetic non-β-lactam, β-lactamase inhibitor that inhibits the activities of Ambler class A and C β-lactamases and…”
Get full text
Journal Article -
6
Ceftolozane/Tazobactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination with Activity Against Multidrug-Resistant Gram-Negative Bacilli
Published in Drugs (New York, N.Y.) (2014)“…Ceftolozane is a novel cephalosporin currently being developed with the β-lactamase inhibitor tazobactam for the treatment of complicated urinary tract…”
Get full text
Journal Article -
7
Tedizolid: A Novel Oxazolidinone with Potent Activity Against Multidrug-Resistant Gram-Positive Pathogens
Published in Drugs (New York, N.Y.) (01-02-2015)“…Tedizolid phosphate is a novel oxazolidinone prodrug (converted to the active form tedizolid by phosphatases in vivo) that has been developed and recently…”
Get full text
Journal Article -
8
New Lipoglycopeptides: A Comparative Review of Dalbavancin, Oritavancin and Telavancin
Published in Drugs (New York, N.Y.) (01-05-2010)“…Dalbavancin, oritavancin and telavancin are semisynthetic lipoglycopeptides that demonstrate promise for the treatment of patients with infections caused by…”
Get full text
Journal Article -
9
Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin
Published in Expert review of anti-infective therapy (01-04-2012)“…Plazomicin (formerly ACHN-490) is a next-generation aminoglycoside that was synthetically derived from sisomicin by appending a hydroxy-aminobutyric acid…”
Get more information
Journal Article -
10
Ceftaroline: A Novel Broad-Spectrum Cephalosporin with Activity against Meticillin-Resistant Staphylococcus aureus
Published in Drugs (New York, N.Y.) (01-01-2009)“…Ceftaroline is a broad-spectrum cephalosporin currently under clinical investigation for the treatment of complicated skin and skin-structure infections…”
Get full text
Journal Article -
11
Correction to: Imipenem–Relebactam and Meropenem–Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations
Published in Drugs (New York, N.Y.) (01-05-2018)“…Section heading 5.2, which currently reads 5.2 Meropenem–Relebactam…”
Get full text
Journal Article -
12
The new fluoroquinolones: A critical review
Published in Canadian journal of infectious diseases (1999)“…This paper reviews the literature available on the new fluoroquinolones - clinafloxacin, gatifloxacin, grepafloxacin, levofloxacin, moxifloxacin, sparfloxacin…”
Get full text
Journal Article -
13
Ceftobiprole: A Review of a Broad-Spectrum and Anti-MRSA Cephalosporin
Published in American journal of clinical dermatology (01-01-2008)“…Ceftobiprole, an investigational cephalosporin, is currently in phase III clinical development. Ceftobiprole is a broad-spectrum cephalosporin with…”
Get full text
Journal Article -
14
Comment: Clinical Pharmaceutics and Calcium–Ceftriaxone
Published in The Annals of pharmacotherapy (01-03-2008)Get full text
Journal Article -
15
Review of macrolides and ketolides: Focus on respiratory tract infections
Published in Drugs (New York, N.Y.) (2001)“…The first macrolide, erythromycin A, demonstrated broad-spectrum antimicrobial activity and was used primarily for respiratory and skin and soft tissue…”
Get full text
Journal Article -
16
Clinical pharmaceutics and calcium-ceftriaxone
Published in The Annals of pharmacotherapy (01-03-2008)Get full text
Journal Article -
17
The ketolides: A critical review
Published in Drugs (New York, N.Y.) (2002)“…Ketolides are a new class of macrolides designed particularly to combat respiratory tract pathogens that have acquired resistance to macrolides. The ketolides…”
Get full text
Journal Article -
18
A critical review of oxazolidinones: an alternative or replacement for glycopeptides and streptogramins?
Published in Canadian journal of infectious diseases (2001)“…To review the available data on the oxazolidinones linezolid and eperezolid. Published reports were obtained by searching MEDLINE for articles published…”
Get full text
Journal Article -
19
Dalbavancin and telavancin: novel lipoglycopeptides for the treatment of Gram-positive infections
Published in Expert review of anti-infective therapy (01-02-2008)“…Two glycopeptide analogues of vancomycin and teicoplanin have been developed with improved pharmacokinetic/pharmacodynamic parameters. Dalbavancin was derived…”
Get more information
Journal Article -
20
A Review of New Fluoroquinolones : Focus on their Use in Respiratory Tract Infections
Published in Treatments in respiratory medicine (2006)“…The new respiratory fluoroquinolones (gatifloxacin, gemifloxacin, levofloxacin, moxifloxacin, and on the horizon, garenoxacin) offer many improved qualities…”
Get full text
Journal Article